浙江寿仙谷医药股份有限公司

Name

浙江寿仙谷医药股份有限公司

Legal name

浙江寿仙谷医药股份有限公司

Website

https://sxgoo.com

Company type

Public

Founded year

1993

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Traditional Chinese Medicine / Rare Herbal Health Products

NAICS

Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412)

SIC

Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)

akta.pro primary industry

Herbal & Botanical Supplements (CRADAGAD)

akta.pro secondary industries

Vitamins & Minerals (Single Nutrients) (CRADAGAB), Healthy Aging & Cognitive Support Supplements (CRADAGAM), Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts) (AFAJAKAD)

Keywords

• Traditional chinese medicine
• Ganoderma spore powder
• Dendrobium officinale
• Medicinal herb cultivation
• Herbal health supplements

Headquarters

HQ city

武义县

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. 保健食品及中药产品销售: 通过线上官方商城和线下医药馆渠道销售以灵芝孢子粉、铁皮枫斗、西红花系列为核心的保健食品和中药产品。核心产品包括去壁灵芝孢子粉颗粒、破壁灵芝孢子粉、铁皮枫斗颗粒/浸膏、西红花铁皮枫斗膏等。产品单价从38元(初级农产品香菇)到9900元(礼盒装)不等。

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Zhejiang Shouxiangu Pharmaceutical cultivates, processes, and sells rare Traditional Chinese Medicine herbal products, with its core line being wall-removed Ganoderma lucidum spore powder (灵芝孢子粉), supplemented by Dendrobium officinale (铁皮石斛) and Saffron (西红花) product series. Production is vertically integrated through an organic cultivation base of more than 5,000 mu and proprietary processing technology, and finished products are sold through an official e-commerce platform and a network of 50+ Chinese medicine pharmacies.

Product overview

浙江寿仙谷医药股份有限公司 (Shouxiangu) is a listed pharmaceutical and health product company (Stock Code: 603896) specializing in traditional Chinese medicine products. The company operates a complete TCM industry chain from breeding, organic cultivation, deep processing, to product development. Their core product portfolio consists of three main categories: (1) Ganoderma Lucidum Spore Powder Series including third-generation wall-removed spore powder granules and broken-wall spore powder capsules; (2) Dendrobium Officinale (铁皮枫斗) Series including granules and compound extracts with ganoderma; (3) Saffron (西红花) Series including saffron dendrobium paste. The company also offers primary agricultural products like mushrooms. All products are sold through their official e-commerce platform (dzd.sxgoo.com) and distributed through renowned traditional Chinese medicine pharmacies across China.

Differentiator

Problem solved

Functional benefit

Brands

• 寿仙谷牌: Primary product brand covering Ganoderma lucidum spore powder, Dendrobium officinale, and saffron series health products

Products and services

• Wall-removed Ganoderma lucidum spore powder (灵芝孢子粉)

Quantifiable outcome

• 去壁灵芝孢子粉总多糖含量较破壁孢子粉提高近12倍
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

14 partnerships are on record, tiered 重要 and 核心.

• 澳门科技大学重要Strategic or Co-development Partner · 1 November 20162016年11月，寿仙谷在上海与澳门科技大学联合承办了ISO/TC249第一工作组第8次会议。
• 胡庆余堂核心Channel Partner/ Reseller/ Distributor寿仙谷中药炮制技艺被列入国家非物质文化遗产名录，寿仙谷公司被认定为中华老字号企业，成为胡庆余堂等五十多个百年老字号医药馆的热销品牌。
• 方回春堂核心Channel Partner/ Reseller/ Distributor方回春堂等五十多个百年老字号医药馆热销寿仙谷产品。
• 同仁堂核心Channel Partner/ Reseller/ Distributor同仁堂等五十多个百年老字号医药馆热销寿仙谷产品。
• 雷允上核心Channel Partner/ Reseller/ Distributor雷允上等五十多个百年老字号医药馆热销寿仙谷产品。
• 京东健康重要GTM or Marketing Partner在第五届中国·寿仙谷灵芝文化节上，寿仙谷携手京东健康推出联名款新品，共同发布《灵芝品类健康消费白皮书》，推动灵芝从传统滋补迈向精准健康。
• 美国梅奥医学中心重要Strategic or Co-development Partner与美国梅奥医学中心合作开展去壁灵芝孢子粉抗肿瘤/提高免疫分子作用机制研究，共同申请专利(去壁灵芝孢子粉对心血管功能的影响，2022年)。
• 北京大学重要Strategic or Co-development Partner与北京大学合作开展去壁灵芝孢子粉药理药效和临床研究。
• 浙江大学重要Strategic or Co-development Partner与浙江大学合作开展去壁灵芝孢子粉药理药效研究。
• 中国中医科学院重要Strategic or Co-development Partner与中国中医科学院共同提交灵芝和铁皮石斛两个国际标准提案的立项申请并获得通过。
• 世界食用菌生物学及产品学会重要Strategic or Co-development Partner在第五届灵芝文化节上与世界食用菌生物学及产品学会联合发布《灵芝品类健康消费白皮书》。
• 浙江省中医药学会、浙江省中药材产业协会、胡庆余堂、方回春堂、联华华商集团等重要Strategic or Co-development Partner在第五届灵芝文化节上共同启动《推进灵芝产业高质量发展行动宣言》，提出科技创新、质量监管、产学研合作、拓展市场渠道、弘扬灵芝文化五大行动宣言。
• 浙江省人民医院重要Strategic or Co-development Partner与浙江省肿瘤医院合作开展去壁灵芝孢子粉在免疫调节与肿瘤协同治疗学术交流。
• 浙江省珍稀植物药工程技术研究中心核心Strategic or Co-development Partner寿仙谷核心研发平台，与该中心合作开展去壁与破壁灵芝孢子粉吸收情况比较研究。

Scale indicators9 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Hu Qing Yu Tang: Century-old China Time-Honored Brand TCM pharmacy with similar premium herbal medicine and health product offerings. Directly comparable as a peer brand and distribution partner (currently a Shouxiangu channel customer), competing in the same premium TCM retail and consumer segment.
• Beijing Tongrentang: China's most iconic TCM pharmacy chain and China Time-Honored Brand, manufacturing and selling premium herbal medicines including tonics and spore powder products. Highly comparable to Shouxiangu on heritage brand positioning, herbal product portfolio, and pharmacy distribution model.
• Yunnan Baiyao Group: Leading Chinese TCM and consumer health company combining proprietary traditional formulations with branded health products, listed on Shenzhen Stock Exchange. Comparable on TCM heritage, proprietary formulation technology, vertically integrated supply, and broad consumer health positioning.
• Pi Wei (碧生源): Chinese herbal health products company specializing in TCM-based functional foods and dietary supplements with strong e-commerce presence. Comparable on Chinese herbal health positioning, branded consumer marketing, and online/offline multi-channel distribution.
• Yiling Pharmaceutical: Chinese TCM and pharmaceutical company focused on traditional Chinese medicine products with proprietary formulations and modern clinical research backing. Comparable on TCM product positioning, R&D investment, and clinical evidence-based marketing of traditional botanicals.
• Infinitus (LKK Health Products): Major Chinese direct-selling and herbal health products company with proprietary TCM-based functional health products, including herbal tonics and immune support. Comparable in herbal supplement category, premium pricing strategy, and Chinese consumer health positioning, though distributed primarily through direct sales.
• Korea Ginseng Corporation (Cheong Kwan Jang): Korean state-backed premium herbal supplement company specializing in Korean red ginseng products with proprietary varieties, vertical integration, and global distribution. Directly comparable business model to Shouxiangu's Ganoderma business: single-heritage botanical, proprietary cultivation, premium branded health products, and international export focus.

Broad incumbents

• Guangzhou Pharmaceutical Holdings: One of China's largest pharmaceutical conglomerates with extensive TCM, chemical drug, and health product portfolio, listed on Hong Kong and Shanghai exchanges. Operates broader healthcare business but overlaps with Shouxiangu in TCM and consumer health products at much larger scale.
• Amorepacific (Health & Food): South Korean conglomerate with a health supplement division featuring traditional herbal (ginseng, red ginseng) and functional health products. Comparable in Asian premium herbal supplement positioning, brand-led marketing, and overseas export ambitions, though Amorepacific is primarily a beauty conglomerate.

Regional players

• Eu Yan Sang: Singapore-headquartered heritage TCM brand with proprietary Chinese herbal products, retail clinics, and pan-Asian distribution. Comparable on traditional Chinese medicine heritage positioning, premium pricing, and Chinese botanical product portfolio, but primarily serves Southeast Asia/Hong Kong rather than mainland China.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/%E6%B5%99%E6%B1%9F%E5%AF%BF%E4%BB%99%E8%B0%B7%E5%8C%BB%E8%8D%AF%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 浙江寿仙谷医药股份有限公司